Clinical Trials Browser

Phase 2/3 × Eicosapentaenoic Acid × Gastrointestinal × Clear all

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Phase 2/3 Completed

58 enrolled 12 charts

Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps